Anesthetic considerations for the pediatric oncology patient – part 2: systems‐based approach to anesthesia
- 8 April 2010
- journal article
- review article
- Published by Wiley in Pediatric Anesthesia
- Vol. 20 (5) , 396-420
Abstract
Summary: One of the prices paid for chemo‐ and radiotherapy of cancer in children is damage to the vulnerable and developing healthy tissues of the body. Such damage can exist clinically or subclinically and can become apparent during active antineoplastic treatment or during remission decades later. Furthermore, effects of the tumor itself can significantly impact the physiologic state of the child. The anesthesiologist who cares for children with cancer or for survivors of childhood cancer should understand what effects cancer and its therapy can have on various organ systems. In part two of this three‐part review, we review the anesthetic issues associated with childhood cancer. Specifically, this review presents a systems‐based approach to the impact from both tumor and its treatment in children, followed by a discussion of the relevant anesthetic considerations.Keywords
This publication has 250 references indexed in Scilit:
- Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published FindingsJournal of Clinical Oncology, 2009
- Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2009
- Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase‐associated pancreatitisPediatric Blood & Cancer, 2009
- American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late EffectsJournal of Clinical Oncology, 2007
- Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up studyEuropean Journal of Cancer, 2006
- Chronic GVHD and Pretransplantation Abnormalities in Pulmonary Function Are the Main Determinants Predicting Worsening Pulmonary Function in Long-term Survivors after Stem Cell TransplantationTransplantation and Cellular Therapy, 2006
- Cardiotoxicity of Cancer ChemotherapyPediatric Drugs, 2005
- Hepatotoxicity of ChemotherapyThe Oncologist, 2001
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiationEuropean Journal of Cancer, 1996